Resources
The latest in immuno research, from the discovery & development of cell & antibody therapies through to omics-based approaches and clinical case studies
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Biomarkers in Immuno-Oncology
New Multi-Omic AI-Driven Initiative for Immuno-Oncology Biomarker Development
The team aims to establish a consortium of cancer centres to join the project of developing biomarkers from multi-omic analysis.
Biomarkers in Immuno-Oncology
Oncolytic Virus Immunotherapy: A Revolutionary Approach in Immuno-Oncology
Explore the cutting-edge of oncolytic virus immunotherapy in immuno-oncology: the viruses revolutionizing cancer treatment and the promise they hold for future therapies.
Biomarkers in Immuno-Oncology
Translating the Complex Immune System Into Disease Insights With CyTOF Technology
Reasons to choose CyTOF.
Biomarkers in Immuno-Oncology
NeoGenomics: Connect With Us to Explore How Our Oncology Data and Expertise Can Help Your Team
Data-driven insights from the largest volume cancer-testing lab in the U.S.
Biomarkers in Immuno-Oncology
Scaling Comparative Lung Cancer Studies Using Chromium Single Cell Gene Expression Flex
Biomarkers in Immuno-Oncology
TruCulture: A Simple Whole Blood Collection and Culture System for Clinical Immunology Studies
Biomarkers in Immuno-Oncology
Simplify Spatial Imaging Maxpar IMC Cell Segmentation Kit
High-plex imaging starts with robust cell segmentation
Biomarkers in Immuno-Oncology
Bioanalytical Solutions for CAR-T and NK Cell Therapies
Synexa Life Sciences is a bioanalytical and biomarker services laboratory specializing in the development and validation of complex and custom designed assays with progression into clinical trial sample analysis.
Biomarkers in Immuno-Oncology
Synexa Life Sciences: Bioanalytical Solutions for Immuno-oncology Therapeutics
Global leaders in specialist biomarker and bioanalysis research services.
Biomarkers in Immuno-Oncology
Synexa Biomarker and Bioanalytical Solutions
Complex solutions delivered on time and within budget.
Biomarkers in Immuno-Oncology
Rules Based Medicine: Human Services Catalog
Rules-Based Medicine (RBM), a Q2 Solutions Company, is a CLIA-certified immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services and products.
Biomarkers in Immuno-Oncology
Rules Based Medicine: Operational Procedures
Rules-Based Medicine (RBM), a Q2 Solutions Company, has spent over 20 years developing and optimizing multiplex immunoassays based on the Luminex xMAP® technology.
Biomarkers in Immuno-Oncology
NeoGenomics: Transforming Care for Cancer Patients
Comprehensive service overview for pharmaceutical partners
Biomarkers in Immuno-Oncology
SyncroPatch 384 For All Your Patch Clamp Needs
Unprecedented flexibility for HTS automated patch clamp.
Biomarkers in Immuno-Oncology
Nanion: Cell Analytics Brochure
Next level live-cell kinetic and phenotypic assays.
Biomarkers in Immuno-Oncology
AtlaZ: Quantitative Live-Cell Analytics
Welcome to the next level of live-cell analytics.
Biomarkers in Immuno-Oncology
Immune Cell-mediated Killing of A549 Cancer Target Cells in Real-time
Nanion Technologies GmbH, Munich. TUM, Munich
Biomarkers in Immuno-Oncology
Exploring Oncology Biomarkers in Early Clinical Trials and Precision Medicine: Challenges and Opportunities
The importance of validating hypotheses, understanding the biology of cancer progression, and utilising biomarkers in early screening to stratify populations and improve clinical endpoints.
Biomarkers in Immuno-Oncology
A ‘New Age’ of Biomarker Technology? Understanding Identification & Validation of IO Biomarkers
Developing and validating IO biomarkers present challenges, such as working with challenging sample types, interpreting sequencing data, and integrating new technologies into the clinic.
Biomarkers in Immuno-Oncology
Axion Biosystems: Organoid Analysis Module
Robust organoid quantification and monitoring.
Biomarkers in Immuno-Oncology
Volition: Nu.Q Discover
An innovative solution to profiling nucleosomes.
Biomarkers in Immuno-Oncology
ChemPartner: GPCR/Transporter/Ion Channel Screening
Overview of Capabilities.
Biomarkers in Immuno-Oncology
Improving Patient Response Through Effective Biomarker Development
Oxford Global's panel discussion brings together expert scientists in the field of immunology and biomarker development.
Biomarkers in Immuno-Oncology
Enabling Ultrasensitive Protein Quantification with the Quanterix Homebrew Kit
Unique Homebrew Kits give researchers the flexibility to develop custom Simoa assays.
Biomarkers in Immuno-Oncology
Three Leading Perspectives on Biomarker Diagnostic Discovery in Immuno-oncology
Early and effective treatment of cancers could mean the difference between life and death. Therefore, companion diagnostics and biomarker discovery could be considered one of the most important avenues to explore in immuno-oncology.
Biomarkers in Immuno-Oncology
Perfecting Precision Medicine: The Promise of Biomarkers and Spatial Biology
What is the future of precision medicine for immuno-oncology, and how can we achieve it? In this Insight Article, we sat down with senior representatives from the University of Michigan, the Beth Israel Deaconess Medical Center / Harvard Medical School, and The Institute of Cancer Research, London, to discover more about harnessing the potential of spatial biology and predictive biomarkers to achieve targeted results.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things immuno